Shares of pharmaceutical giant Pfizer (NYSE: PFE) are currently trading below $25, marking a decline of approximately 60% ...

The cost of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the ...

Jim Cramer has a reputation for getting market calls wrong, but what if you put $1,000 in Inverse Cramer at the start of 2025 ...

Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues.

How $2,670 split across three durable high-yield stocks can generate $300 in annual dividends without risky payouts.

Given the stock's less-than favorable performance during the last few years as it emerged from its pandemic growth days and ...

Pfizer Inc. (NYSE:PFE) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 16, Pfizer Inc. (NYSE ...

We regret to report that long term Pfizer Inc. (NYSE:PFE) shareholders have had that experience, with the share price ...

These high-octane dividend stocks -- sporting an average yield of 11.25% -- have the catalysts needed to sustainably pad the ...

Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated ...

Kirill Dmitriev commented on a post by US Secretary of State Marco Rubio about the State Department's intention to take steps to bar leading figures of the global censorship-industrial complex from en ...

Pfizer's Eliquis, a blood thinner and one of its best-selling therapies, will lose patent exclusivity within the next few ...